|
|
|
|
| LEADER |
01572nam a2200313 u 4500 |
| 001 |
EB000944303 |
| 003 |
EBX01000000000000000737893 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309091934
|
| 020 |
|
|
|a 9780309091930
|
| 245 |
0 |
0 |
|a Damp indoor spaces and health
|h Elektronische Ressource
|c Committee on Damp Indoor Spaces and Health, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c c2004, 2004
|
| 300 |
|
|
|a xi, 355 p.
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a Background and methodologic considerations -- Damp buildings -- Exposure assessment -- Toxic effects of fungi and bacteria -- Human health effects associated with exposure to damp buildings -- Prevention and remediation of damp indoor environments -- The public health response
|
| 653 |
|
|
|a Air Microbiology
|
| 653 |
|
|
|a Air Pollution, Indoor / prevention & control
|
| 653 |
|
|
|a Respiratory Tract Diseases / epidemiology
|
| 653 |
|
|
|a Bacterial Toxins / adverse effects
|
| 653 |
|
|
|a Air Pollution, Indoor / adverse effects
|
| 653 |
|
|
|a Mycotoxins / adverse effects
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee on Damp Indoor Spaces and Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK215643
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 576
|